YCBD cbdMD Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: YCBD

Price (delayed)

$1

Market cap

$3.05M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$12.63

Enterprise value

$4.91M

cbdMD, Inc. is one of the world’s leading, most highly trusted health & wellness CBD companies, whose current products include CBD tinctures, CBD capsules, CBD gummies, CBD topicals, CBD botanical ...

Highlights
The EPS has soared by 71% year-on-year and by 5% since the previous quarter
The net income has soared by 64% YoY and by 13% QoQ
YCBD's equity has dropped by 74% year-on-year and by 22% since the previous quarter
The quick ratio has plunged by 54% YoY and by 32% from the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.cbdmd.com

Key stats

What are the main financial stats of YCBD
Market
Shares outstanding
3.05M
Market cap
$3.05M
Enterprise value
$4.91M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.42
Price to sales (P/S)
0.13
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.21
Earnings
Revenue
$23.45M
EBIT
-$19.98M
EBITDA
-$17.13M
Free cash flow
-$2.65M
Per share
EPS
-$12.63
Free cash flow per share
-$0.89
Book value per share
$2.38
Revenue per share
$7.92
TBVPS
$4.07
Balance sheet
Total assets
$15.1M
Total liabilities
$8.06M
Debt
$3.37M
Equity
$7.04M
Working capital
$1.39M
Liquidity
Debt to equity
0.48
Current ratio
1.23
Quick ratio
0.44
Net debt/EBITDA
-0.11
Margins
EBITDA margin
-73.1%
Gross margin
63.8%
Net margin
-85.2%
Operating margin
-83.2%
Efficiency
Return on assets
-97.9%
Return on equity
-141.9%
Return on invested capital
-177%
Return on capital employed
-219%
Return on sales
-85.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

YCBD stock price

How has the cbdMD stock price performed over time
Intraday
8.7%
1 week
-1.96%
1 month
29.87%
1 year
-99.67%
YTD
-3.85%
QTD
7.53%

Financial performance

How have cbdMD's revenue and profit performed over time
Revenue
$23.45M
Gross profit
$14.97M
Operating income
-$19.51M
Net income
-$19.98M
Gross margin
63.8%
Net margin
-85.2%
cbdMD's operating income has soared by 66% YoY and by 13% from the previous quarter
The net income has soared by 64% YoY and by 13% QoQ
YCBD's operating margin has soared by 54% year-on-year and by 11% since the previous quarter
The company's net margin has surged by 50% YoY and by 10% QoQ

Growth

What is cbdMD's growth rate over time

Valuation

What is cbdMD stock price valuation
P/E
N/A
P/B
0.42
P/S
0.13
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.21
The EPS has soared by 71% year-on-year and by 5% since the previous quarter
YCBD's equity has dropped by 74% year-on-year and by 22% since the previous quarter
The stock's P/B is 68% below its 5-year quarterly average of 1.3 but 5% above its last 4 quarters average of 0.4
YCBD's P/S is 95% below its 5-year quarterly average of 2.5 and 35% below its last 4 quarters average of 0.2
The revenue has decreased by 27% YoY and by 2.9% from the previous quarter

Efficiency

How efficient is cbdMD business performance
The ROS has soared by 50% year-on-year and by 10% since the previous quarter
YCBD's ROIC is up by 48% YoY
The company's return on equity fell by 15% QoQ and by 11% YoY
The ROA has contracted by 8% from the previous quarter but it has grown by 6% YoY

Dividends

What is YCBD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for YCBD.

Financial health

How did cbdMD financials performed over time
The total assets is 87% more than the total liabilities
The total assets has plunged by 58% YoY and by 7% from the previous quarter
The quick ratio has plunged by 54% YoY and by 32% from the previous quarter
The company's debt is 52% lower than its equity
The debt to equity has soared by 182% YoY and by 17% QoQ
YCBD's equity has dropped by 74% year-on-year and by 22% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.